Investigation of Microbial Translocation,

CRC TLR VDR colorectal cancer dysbiosis genetic variants microbial translocation polymorphisms

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
10 Sep 2022
Historique:
received: 09 08 2022
revised: 02 09 2022
accepted: 08 09 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 24 9 2022
Statut: epublish

Résumé

Gut microbial dysbiosis and microbial passage into the peripheral blood leads to colorectal cancer (CRC) and disease progression. Toll-like (

Identifiants

pubmed: 36139567
pii: cancers14184407
doi: 10.3390/cancers14184407
pmc: PMC9496848
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Gastrointestinal cancer study group
ID : N/A
Organisme : Hellenic Society of Medical Oncology (HeSMO)
ID : No: 7387 / 19-02-2019

Références

Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2485-91
pubmed: 19706842
Cell Commun Signal. 2020 Jun 10;18(1):90
pubmed: 32522267
World J Gastroenterol. 2012 Apr 14;18(14):1672-9
pubmed: 22529698
Cancer Res Treat. 2019 Oct;51(4):1518-1526
pubmed: 30913862
Cell Biochem Funct. 2007 Nov-Dec;25(6):731-7
pubmed: 17243190
Onco Targets Ther. 2018 Sep 18;11:5963-5971
pubmed: 30271180
Am J Pathol. 2001 Jun;158(6):1985-90
pubmed: 11395375
Oncogene. 2014 Jul 3;33(27):3485-95
pubmed: 23934186
Br J Nutr. 2016 May;115(9):1643-60
pubmed: 27245104
World J Gastroenterol. 2013 Jul 14;19(26):4119-26
pubmed: 23864774
Nat Rev Cancer. 2014 May;14(5):342-57
pubmed: 24705652
Dig Dis Sci. 2009 Mar;54(3):634-9
pubmed: 18618252
Br J Cancer. 2009 Aug 4;101(3):465-72
pubmed: 19603024
Dig Dis Sci. 2012 Jan;57(1):182-8
pubmed: 21755299
Gene. 2004 Sep 1;338(2):143-56
pubmed: 15315818
J Infect Dev Ctries. 2014 Apr 15;8(4):430-40
pubmed: 24727508
Int J Cancer. 2012 Jun 15;130(12):2974-80
pubmed: 21792899
Cancer Sci. 2007 Nov;98(11):1790-4
pubmed: 17711514
Cell. 2010 Mar 19;140(6):805-20
pubmed: 20303872
Oncol Lett. 2020 Oct;20(4):110
pubmed: 32863923
Gastric Cancer. 2010 Nov;13(4):251-7
pubmed: 21128061
Arch Biochem Biophys. 2012 Jul 1;523(1):123-33
pubmed: 22503810
Curr Protoc Immunol. 2015 Apr 01;109:14.12.1-14.12.10
pubmed: 25845562
Cancers (Basel). 2021 Jul 15;13(14):
pubmed: 34298766
Gut. 2015 Jul;64(7):1082-94
pubmed: 25080448
Anticancer Res. 2013 Feb;33(2):543-51
pubmed: 23393347
Nat Rev Cancer. 2007 Sep;7(9):684-700
pubmed: 17721433
Biomed Res Int. 2021 Sep 12;2021:1157023
pubmed: 34552981
Immunol Lett. 2010 Jan 18;128(1):29-35
pubmed: 19895847
Cancers (Basel). 2020 Apr 24;12(4):
pubmed: 32344707
Cancers (Basel). 2022 Jul 07;14(14):
pubmed: 35884381
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Arch Immunol Ther Exp (Warsz). 2019 Jun;67(3):133-141
pubmed: 30976817
Cancers (Basel). 2020 Dec 25;13(1):
pubmed: 33375686
Eur J Cancer Prev. 2016 Jan;25(1):85-96
pubmed: 25738688
Adv Exp Med Biol. 2014;810:69-105
pubmed: 25207361
Cancers (Basel). 2020 May 27;12(6):
pubmed: 32471257
J Natl Cancer Inst. 2015 Jul 09;107(10):
pubmed: 26160882
Nat Med. 2004 Sep;10(9):917-9
pubmed: 15322538
Oncology. 2021;99(9):589-600
pubmed: 34139707
J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):106-9
pubmed: 20138990
Int J Cancer. 2008 Nov 1;123(9):2170-9
pubmed: 18709640
Int J Mol Sci. 2019 Oct 24;20(21):
pubmed: 31653078
Cancer. 2014 May 1;120(9):1387-93
pubmed: 24510435
J Immunother. 2013 Jul-Aug;36(6):342-9
pubmed: 23799413
Science. 2006 Mar 24;311(5768):1770-3
pubmed: 16497887
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Cancers (Basel). 2020 Jul 25;12(8):
pubmed: 32722474
Cancer Epidemiol. 2013 Dec;37(6):905-7
pubmed: 24075799
Tumour Biol. 2014 Dec;35(12):12397-401
pubmed: 25195132
Gastroenterology. 2015 Jan;148(1):88-99
pubmed: 25305506
Ann Surg. 1998 Jan;227(1):1-9
pubmed: 9445103
J Immunol. 2013 Apr 15;190(8):4297-304
pubmed: 23509352
PLoS One. 2018 Jun 8;13(6):e0197327
pubmed: 29883450
Saudi J Gastroenterol. 2015 Mar-Apr;21(2):95-103
pubmed: 25843196
Clin Transl Gastroenterol. 2017 Jun 29;8(6):e103
pubmed: 28662021
Hum Mol Genet. 2015 Apr 15;24(8):2147-62
pubmed: 25552658

Auteurs

Ippokratis Messaritakis (I)

Laboratory of Translational Oncology, Medical School, University of Crete, 70013 Heraklion, Greece.

Asimina Koulouridi (A)

Laboratory of Translational Oncology, Medical School, University of Crete, 70013 Heraklion, Greece.

Eleni Boukla (E)

Laboratory of Translational Oncology, Medical School, University of Crete, 70013 Heraklion, Greece.

Maria Sfakianaki (M)

Laboratory of Translational Oncology, Medical School, University of Crete, 70013 Heraklion, Greece.

Konstantinos Vogiatzoglou (K)

Laboratory of Translational Oncology, Medical School, University of Crete, 70013 Heraklion, Greece.

Michaela Karagianni (M)

Laboratory of Translational Oncology, Medical School, University of Crete, 70013 Heraklion, Greece.

Nikolaos Gouvas (N)

Medical School, University of Cyprus, 20537 Nicosia, Cyprus.

John Tsiaoussis (J)

Department of Anatomy, School of Medicine, University of Crete, 70013 Heraklion, Greece.

Evangelos Xynos (E)

Department of Surgery, Creta Interclinic Hospital of Heraklion, 71305 Heraklion, Greece.

Elias Athanasakis (E)

Department of General Surgery, Heraklion University Hospital, 71100 Heraklion, Greece.

Dimitrios Mavroudis (D)

Laboratory of Translational Oncology, Medical School, University of Crete, 70013 Heraklion, Greece.
Department of Medical Oncology, University General Hospital of Heraklion, 71100 Heraklion, Greece.

Maria Tzardi (M)

Laboratory of Pathology, Medical School, University of Crete, 70013 Heraklion, Greece.

John Souglakos (J)

Laboratory of Translational Oncology, Medical School, University of Crete, 70013 Heraklion, Greece.
Department of Medical Oncology, University General Hospital of Heraklion, 71100 Heraklion, Greece.

Classifications MeSH